David Drutz's Net Worth
$2.77 Thousand
Who is David Drutz?
David Drutz does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Altimmune, Inc., and DARA BioSciences, Inc..
SEC CIK
David Drutz's CIK is 0001428764
Past Insider Trading and Trends
2017 was David Drutz's most active year for acquiring shares with 13 total transactions. David Drutz's most active month to acquire stocks was the month of April. 2015 was David Drutz's most active year for disposing of shares, totalling 13 transactions. David Drutz's most active month to dispose stocks was the month of November. 2012 saw David Drutz paying a total of $68,282.50 for 125,000 shares, this is the most they've acquired in one year. In 2015 David Drutz cashed out on 805,895 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Altimmune, Inc. (ALT) Snapshot price: $6.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +86.42% | 25.74K |
$4.72 | -$4,172.03 | 55.52K |
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
| +1.02% | 300 |
$2.88 | $862.50 | 29.79K |
Aug 15
| |||
Form 4
| +0.69% | 139 |
$2.40 | $333.60 | 20.15K |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
| +5.26% | 1K |
$8.00 | $8,000.00 | 20.01K |
Jun 15
| |||
Form 4
| +6.74% | 1.2K |
$4.50 | $5,400.00 | 19.01K |
May 24
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +0.39% | 70 |
$2.40 | $168.00 | 17.88K |
Jan 25
| |||
Form 4
| +0.79% | 139 |
$2.40 | $333.60 | 17.81K |
Dec 14
| |||
Form 4
| +0.40% | 70 |
$2.40 | $168.00 | 17.67K |
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 23
| |||
Form 4
| +0.34% | 60 |
$2.40 | $144.00 | 17.6K |
Nov 13
| |||
Form 4
| +2,431.46% | 16.85K |
—
|
—
| 17.54K |
Sep 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
| +48.13% | 10K |
$2.21 | $22,097.00 | 30.78K |
Aug 22 - Aug 23
| |||
Form 4
|
∞
| 20.78K |
—
|
—
| 20.78K |
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DARA BioSciences, Inc. No price found
Executive Chairman and CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -20.61K |
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| +32.02% | 25K |
$0.70 | $17,440.00 | 103.07K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +47.10% | 25K |
$1.06 | $26,500.00 | 78.07K |
Sep 17
| |||
Form 4
| +89.05% | 25K |
$0.77 | $19,250.00 | 53.07K |
Jun 8
| |||
Form 4
| +813.54% | 25K |
$0.90 | $22,532.50 | 28.07K |
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
| +25.53% | 10K |
—
|
—
| 49.17K |
Jan 4
| |||
Form 4
| +11.91% | 4.17K |
—
|
—
| 39.17K |
Jan 8
| |||
Form 4
|
∞
| 35K |
—
|
—
| 35K |
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||